Gritstone bio to Report First Quarter 2024 Financial Results and Provide Corporate Updates on May 9, 2024
— Conference call and webcast to begin at 4:30pm ET —
EMERYVILLE, Calif., May 02, 2024 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq:GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced it will report financial results for the first quarter 2024 and provide corporate updates after market close on Thursday, May 9, 2024. The announcement will be followed by a conference call and audio webcast, which will begin at 4:30pm ET.